Molecules/REGDANVIMAB

REGDANVIMAB

Molecular Identity

AntibodyApprovedFirst approved 2021

Mechanism of action: Spike glycoprotein inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

CT-P59CTP-59CTP59REGDANVIMABREGKIRONA

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to REGDANVIMAB

Loading drug network...